BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38513130)

  • 1. Chronic Radiation Dermatitis Secondary to Narrow-Band Ultraviolet B Therapy in a Patient With Primary Cutaneous CD8 + T-Cell Lymphoma With Cytotoxic Granules.
    Edelson MP; Gay JJ; Thiel RW; Grider DJ
    Am J Dermatopathol; 2024 May; 46(5):312-315. PubMed ID: 38513130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma.
    Morse DC; Park KE; Chitsazzadeh V; Li S; Young K; Gunther JR; Dabaja BS; Duvic M
    Int J Gynecol Pathol; 2021 May; 40(3):229-233. PubMed ID: 33741766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma resembling pemphigus vulgaris.
    Gilkey TW; Pettit C; Korman A; Plaza JA; Trinidad J
    Int J Dermatol; 2022 Oct; 61(10):1298-1300. PubMed ID: 34633071
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous aggressive epidermotropic CD8 positive cytotoxic T-cell lymphoma of the ear.
    Fika Z; Karkos PD; Badran K; Williams RE
    J Laryngol Otol; 2007 May; 121(5):503-5. PubMed ID: 17166330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aggressive T cytotoxic CD8+ epidermotropic cutaneous lymphoma: a case in a patient with Steinert's myotonic dystrophy].
    Du-Thanh A; Durand L; Costes V; Guillot B; Dereure O
    Ann Dermatol Venereol; 2006 Dec; 133(12):991-4. PubMed ID: 17185931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
    Kim SK; Kim YC; Kang HY
    J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
    Wang L; Gao T; Wang G
    J Cutan Pathol; 2015 Apr; 42(4):271-5. PubMed ID: 25458991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Facial ulcerated nodules revealing primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma].
    Rolland M; Dinulescu M; Saillard C; Battistella M; Le Gall F; Lhomme F; Gangneux JP; Dupuy A; Adamski H
    Ann Dermatol Venereol; 2020 Nov; 147(11):764-768. PubMed ID: 32527516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma?
    Miyauchi T; Abe R; Morita Y; Adachi M; Shiba K; Hamade Y; Saito N; Nishimura M; Ibata M; Okada K; Shigematsu A; Endo T; Kawai K; Teshima T; Shimizu H
    Acta Derm Venereol; 2015 Nov; 95(8):1024-5. PubMed ID: 25792011
    [No Abstract]   [Full Text] [Related]  

  • 11. Bexarotene and DAB(389)IL-2 (denileukin diftitox, ONTAK) in treatment of cutaneous T-cell lymphomas: algorithms.
    Duvic M
    Clin Lymphoma; 2000 Nov; 1 Suppl 1():S51-5. PubMed ID: 11707865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Cutaneous CD8+ T-cell Lymphoma, an Indolent and Locally Aggressive Form Mimicking Paronychia.
    Beggs SM; Friedman BJ; Kornreich D; Okon L; Alpdogan O; Shi W; Sahu J
    Am J Dermatopathol; 2018 Apr; 40(4):e52-e56. PubMed ID: 28984695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous CD8+ aggressive epidermotropic T-cell lymphoma mimicking pyoderma gangrenosum.
    Flora A; Gibson M; Toon C; Rawson R; Lowe P
    Indian J Dermatol Venereol Leprol; 2021; 88(1):90-92. PubMed ID: 34951938
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal Case of Primary Cutaneous Aggressive T-Cell Lymphoma Switching From a CD4+ to a CD8+ Phenotype: Progressive Disease With Bexarotene and Romidepsin Treatment.
    Johnson WT; Leeman-Neill RJ; Patel P; Ho J; Grandinetti LM; Jedrych J; Craig FE
    Am J Dermatopathol; 2016 Nov; 38(11):832-837. PubMed ID: 27322928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous CD8+ epidermotropic cytotoxic T-cell lymphoma with aggressive course].
    Poszepczynska-Guigné E; Jagou M; Wechsler J; Dieng MT; Revuz J; Bagot M
    Ann Dermatol Venereol; 2006 Mar; 133(3):253-6. PubMed ID: 16800177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Cord Blood Stem Cell Transplantation for Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated with Cerebral Infiltration.
    Ichikawa S; Fukuhara N; Hatta S; Himuro M; Katsushima H; Nasu K; Ono K; Inokura K; Kobayashi M; Onishi Y; Fujii H; Ishizawa K; Ichinohasama R; Harigae H
    Intern Med; 2018 Jul; 57(14):2051-2055. PubMed ID: 29526962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
    J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.
    Geller S; Hollmann TJ; Horwitz SM; Myskowski PL; Pulitzer M
    Histopathology; 2020 Jan; 76(2):222-232. PubMed ID: 31355940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indolent CD8-positive T-cell lymphoid proliferation of the ear: a report of two cases.
    Zeng W; Nava VE; Cohen P; Ozdemirli M
    J Cutan Pathol; 2012 Jul; 39(7):696-700. PubMed ID: 22612273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation.
    Nofal A; Abdel-Mawla MY; Assaf M; Salah E
    J Am Acad Dermatol; 2012 Oct; 67(4):748-59. PubMed ID: 22226429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.